H5N1 strains have been circulating among wild and domestic birds in the U.S. since 2021. In 2024, it began to cause outbreaks ...

The first ever avian influenza vaccine recently started trials in the UK. This marks a milestone in the prevention of bird flu infections in humans. The vaccine targets the H5N1 flu strain, which ...

Bird flu cases reported in parts of Maharashtra have triggered fresh public health concern, especially after infected poultry ...

Hantavirus and bird flu are viral infections that can spread to humans under certain conditions. Here is what the WHO says ...

A heron in Kannur's Ayyikara harbour area tested positive for H5N1, marking the district's first such case and prompting heightened surveillance measures.

Rare feline infection: A cat in southeastern Saskatchewan died suddenly from H5N1 avian flu, confirmed by federal and provincial labs. Seasonal risk spike: Officials warn spring migration increases ...

Traws Pharma is responding to the threat of Hantavirus, a rodent-borne negative-strand RNA virus that typically results in a 30-50% fatality rate when transmitted to humans and which has been ...

Traws Pharma already develops antiviral drugs for influenza, H5N1 bird flu, and COVID-19. ・Hantavirus is a severe rodent-borne disease with a fatality rate of 30% to 50% in humans. ・The World Health ...

Traws Pharma, Inc. (NASDAQ: TRAW) ("Traws Pharma", "Traws" or "the Company"), a clinical-stage biopharmaceutical company developing novel therapies to target ...

Sask. vets were sent a memo asking for vigilance after a domestic cat died from contracting the "highly pathogenic avian ...

Heron tests positive for bird flu in Kannur, prompting public alerts and increased surveillance measures in the area.

Traws Pharma, Inc. (NASDAQ: TRAW) shares reported sharp gains to begin Friday trade. The Newtown, Pa.-based company, a clinical-stage biopharmaceutical concern developing novel therapies to target ...